Anne Bertasso Selected Research

Fatigue

12/2005

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Bertasso Research Topics

Disease

3	Infections 01/2015 - 09/2007
2	Body Weight (Weight, Body) 04/2007 - 12/2004
1	Coinfection 05/2012
1	Liver Diseases (Liver Disease) 05/2012
1	Needlestick Injuries (Needlestick Injury) 01/2011
1	Chronic Hepatitis C 01/2011
1	Pneumonia (Pneumonitis) 12/2005
1	Diarrhea 12/2005
1	Lymphadenopathy 12/2005
1	Fatigue 12/2005
1	Injection Site Reaction 12/2005
1	Nausea 12/2005

Drug/Important Bio-Agent (IBA)

4	Enfuvirtide (Fuzeon)FDA Link 09/2007 - 12/2004
2	peginterferon alfa-2a (Pegasys)FDA Link 05/2012 - 01/2011
1	Antiviral Agents (Antivirals)IBA 01/2015
1	Ribavirin (Virazole)FDA LinkGeneric 05/2012
1	RNA (Ribonucleic Acid)IBA 05/2012
1	Pharmaceutical PreparationsIBA 12/2004

Therapy/Procedure

3	Therapeutics 01/2015 - 09/2007